Articles > Popular publications > PR Newswire press releases > January-March 2006 > Tuesday, February 28

Article: Nastech's Facility Approved for Commercial Manufacturing of Calcitonin-Salmon Nasal Spray for Treatment of Osteoporosis.

Article from:
PR Newswire
Article date:
February 28, 2006
Copyright

BOTHELL, Wash., Feb. 28 /PRNewswire-FirstCall/ -- Nastech Pharmaceutical Company Inc. , a leader in developing therapeutics using advanced molecular biology-based drug delivery technologies, announced today the successful completion of the FDA's Pre-Approval Inspection (PAI) of its Bothell, Washington facility. Successful completion of this PAI enables Nastech to manufacture calcitonin-salmon nasal spray for commercial use upon FDA approval of the Company's ANDA (Abbreviated New Drug Application), which the FDA accepted for filing in February 2004.

In June 2005, Nastech announced the successful completion of a PAI for manufacturing of calcitonin-salmon nasal ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Nastech Reacquires Teriparatide (Parathyroid Hormone; ...
PR Newswire;  November 7, 2007 ;     700+ words ... ... commercialization agreement for PTH1-34 Nasal Spray. Nastech will immediately advance PTH1-34 Nasal Spray into a Phase 2 clinical study to ... work completed, demonstrate that Nastech's patented nasal spray formulation delivers teriparatide ...

Article: Nastech Reports Positive PYY Nasal Spray ...
PR Newswire;  December 21, 2006 ;     700+ words ... ... Intravenous and PYY Nasal Spray Produce Satiety ... FirstCall/ -- Nastech Pharmaceutical ... various doses of Nastech's proprietary PYY(3-36) nasal spray in obese subjects ... delivery technology, Nastech developed the nasal spray formulation of ...

Article: Nastech Pharmaceutical Company Announces Initiation of ...
PR Newswire;  October 1, 2007 ;     700+ words ... ... different doses of Nastech's PYY3-36 Nasal Spray compared to placebo ... clinicaltrials.gov/. "Nastech has developed a ... non-invasive nasal spray dosage form of a ... delivery technology, Nastech developed the nasal spray formulation of PYY ...

Article: Nastech Pharmaceutical Company Announces Initiation of ...
PR Newswire;  September 26, 2007 ;     700+ words ... ... control. Data from Nastech's earlier Phase ... Company's Insulin Nasal Spray achieved faster ... different doses of Nastech's Insulin Nasal Spray compared to NovoLog ... begin in October. "Nastech's Insulin Nasal Spray has the potential ...

Article: Nastech to Manufacture Nascobal(R) Nasal ...
PR Newswire;  October 17, 2005 ;     700+ words ... ... Cyanocobalamin, USP) Nasal Spray for the treatment ... Pharmaceuticals, Inc. , Nastech will be the ... identified in Nastech's NDA for Nascobal Nasal Spray. Additional ... Nascobal." "Nastech looks forward ... supplying Nascobal Nasal Spray to QOL and will ...

Article: Nastech Initiates Clinical Development of Rapid Acting ...
PR Newswire;  September 19, 2006 ;     700+ words ... ... Inhalation Powder. Nastech's insulin nasal spray could provide patients ... and several different Nastech insulin nasal spray doses on separate days ... tolerability of the insulin nasal spray doses. "Nastech's initiation of human ...

Article: Nastech Submits Investigational New Drug Application for ...
PR Newswire;  June 7, 2006 ;     700+ words ... ... potential for PYY nasal spray to treat obesity ... President and CEO of Nastech. "We have been ... technology, Nastech developed the nasal spray formulation of ... hypertension. PYY nasal spray may offer a novel ... condition. About Nastech Nastech is a ...

Article: Nastech Enters Into Supply Agreement with Procter & Gamble ...
PR Newswire;  June 6, 2006 ;     700+ words ... ... agreement for PTH1-34 nasal spray that was announced ... supply agreement, Nastech will be the exclusive ... of the PTH1-34 nasal spray for P&G ... agreement with Nastech as it secures sufficient ... commercialization of PTH1-34 nasal spray, if approved ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives